You are here

  • Home
  • Archive
  • Volume 30, Issue Suppl 4
  • 392 Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation: subgroup analysis by risk in the phase III solo1 study

Citation Tools

Article menu

Download PDFPDF

Ovarian cancer
392 Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation: subgroup analysis by risk in the phase III solo1 study
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Colombo N, Bradley W, Moore K, et al
392 Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation: subgroup analysis by risk in the phase III solo1 study
International Journal of Gynecologic Cancer 2020;30:A76-A77.